60.89
GBA's "2021 Stock Phantasma"
- Thread starter stonedinvestor
- Start date
60.89
ATOS IS COMING ACROSS THE CNBC MUCH HIGHER +7O CENTS @ $3.60!!!!AH
Hmmmm.... somehow I think you're gonna submit an entry...
EDIT
there ya go
(as i plow through your posts)
Stoney: $55.20
VVVVVV
Not a bad guess imo.
I like $54
Pretty sure the straddle pricing at about $8 will hold regardless of where it closes tomorrow.
Its a crowded trade.
GBA LOVES THIS STOCK...
I would say wait for a pullback, I have before.... but this bit** is a strong stock.
The last one I saw that behaved like this... was NVDA @ $70.
.... that said.... DO NOT LISTEN TO ME.
For real.
Do your own dd.
Last edited:
Are you dating Cramer?
Its up 16% ah's
wtfffffffff!?
Ok.... this is beyond luck.
You're going to jail.
What was that scene from Pulp Fiction?
"I don't know you....
....Prank caller!
....Prank caller!"
OK, so, bioplastics.... I'm trying to learn about this field and see if I can find a few good companies. There's a lot to learn, but here's one that I found that I liked and did a little reading about and bought some shares of. It's inexpensive and the chart has a consistent climb. They might show profits in their next report. Bioplastics is definitely a long game.
Secos Group Ltd
ASX: SES
0.34
'A leading developer and manufacturer of sustainable packaging materials. SECOS supplies its proprietary biodegradable and compostable resins, packaging products and high-quality cast films...' They have several patents. Based in Australia.
Chairman:
Secos Group Ltd
ASX: SES
0.34
'A leading developer and manufacturer of sustainable packaging materials. SECOS supplies its proprietary biodegradable and compostable resins, packaging products and high-quality cast films...' They have several patents. Based in Australia.
Chairman:
And the working list of bioplastic / bio-other-stuff stocks...
Stocks from this thread
Danimer Scientific Inc
NYSE: DNMR
45.82
Makes biodegradable resins that can be used to replace plastics with petrochemicals.
Ranpak Holdings Corp
NYSE: PACK
18.41
Ohio-based. Ranpak Holdings Corp. manufactures machines and paper products used in protective paper-based packing for shipping goods and merchandise for e-commerce and industry.
Other Stocks
Avantium NV
OTCMKTS: AVTXF
7 USD
Based in Netherlands
Our lead product is PEF, a novel, plant-based, recyclable and degradable plastic material
Kraig Biocraft Laboratories Inc
OTCMKTS: KBLB
0.16 USD
'It develops and manufactures recombinant spider silks and other high-performance polymers using spider silk gene sequences.'
Lansing, MI
Leaf Resources Ltd
ASX: LER
0.073
Our Glycell™ process significantly reduces the cost of transforming renewable and abundant biomass into high-purity cellulosic sugars, a key ingredient in bio-based production.
Corbion NV (CORB)
51.60 euro. Amsterdam market. It produces bioingredient-based foods, chemicals derived from organic acids, and lactic acid based solutions for the food, chemical and pharmaceutical industries.
Pond Technologies Holdings Inc
OTCMKTS: PNDHF
0.32 USD
Canada-based.'Emissions from smokestacks and other industrial facilities are redirected to large tanks, called bioreactors...Emissions are cleaned, oxygen is output, and algae is grown.'
***************
Not a bioplastic but they have a strange new insulating paint
EcoDepot OTCMKTS: ECDP
2.69 USD
Nevada. "Eco Depot, Inc. acquires, manages, and develops eco-friendly real estate assets and consumer brand products."
It is commercializing Bronya Climate Shield insulating paint. The roll out is just starting. "By improving energy efficiency in buildings, the product reduces energy costs in structures by as much as 40%. Additionally, it also maintains low to zero volatile organic compounds, providing an environmentally friendly option."
Stocks from this thread
Danimer Scientific Inc
NYSE: DNMR
45.82
Makes biodegradable resins that can be used to replace plastics with petrochemicals.
Ranpak Holdings Corp
NYSE: PACK
18.41
Ohio-based. Ranpak Holdings Corp. manufactures machines and paper products used in protective paper-based packing for shipping goods and merchandise for e-commerce and industry.
Other Stocks
Avantium NV
OTCMKTS: AVTXF
7 USD
Based in Netherlands
Our lead product is PEF, a novel, plant-based, recyclable and degradable plastic material
Kraig Biocraft Laboratories Inc
OTCMKTS: KBLB
0.16 USD
'It develops and manufactures recombinant spider silks and other high-performance polymers using spider silk gene sequences.'
Lansing, MI
Leaf Resources Ltd
ASX: LER
0.073
Our Glycell™ process significantly reduces the cost of transforming renewable and abundant biomass into high-purity cellulosic sugars, a key ingredient in bio-based production.
Corbion NV (CORB)
51.60 euro. Amsterdam market. It produces bioingredient-based foods, chemicals derived from organic acids, and lactic acid based solutions for the food, chemical and pharmaceutical industries.
Pond Technologies Holdings Inc
OTCMKTS: PNDHF
0.32 USD
Canada-based.'Emissions from smokestacks and other industrial facilities are redirected to large tanks, called bioreactors...Emissions are cleaned, oxygen is output, and algae is grown.'
***************
Not a bioplastic but they have a strange new insulating paint
EcoDepot OTCMKTS: ECDP
2.69 USD
Nevada. "Eco Depot, Inc. acquires, manages, and develops eco-friendly real estate assets and consumer brand products."
It is commercializing Bronya Climate Shield insulating paint. The roll out is just starting. "By improving energy efficiency in buildings, the product reduces energy costs in structures by as much as 40%. Additionally, it also maintains low to zero volatile organic compounds, providing an environmentally friendly option."
Reddit figured out it has "EV" in the ticker.
Up she goes.
AquaBounty 13M share Spot Secondary priced at $8.50 07:12 AQB Oppenheimer and Lake Street acted as joint book running managers for the offering.
ooops-
Penn National reports Q4 EPS 7c, consensus 24c
1Life Healthcare price target raised to $62 from $42 at Citi 07:08 ONEM Citi analyst Daniel Grosslight raised the firm's price target on 1Life Healthcare to $62 from $42 and keeps a Buy rating on the shares. The anlasayt thinks 1Life's "vital role" in helping with COVID-19 vaccine distribution and administration provides incremental upside to 2021 net patient revenue estimates and will serve as a catalyst for membership growth acceleration.
Stony's PIPE stock--
Advanced Drainage reports Q3 EPS 62c, consensus 47c 06:51 WMS Reports Q3 revenue $486.1M, consensus $407.9M. CEO Scott Barbour commented, "We delivered a record Q3 in FY21. Sales grew 24% year-over-year, driven by 17% non-residential sales growth and 36% residential sales growth as we continued to execute on our material conversion strategy in the favorable demand environment. We experienced strong demand in key growth states in the South and Southeast regions of the U.S., as well as the return of demand in the Western and Northeast regions of the U.S. In addition, sales in the agriculture market increased 33%, driven by the programs we put in place around organizational changes, new product introductions and improving execution in the strong fall selling season. Overall, we executed well this quarter to meet the growing demand for our products and solutions and continue to benefit from our national presence as well as our favorable geographic and end market exposure. We also achieved record profitability in Q3. Our Adjusted EBITDA margin expanded 540-basis points this quarter, our first full quarter of comparable results from the Infiltrator business. In addition to capturing the benefits of leverage from our strong sales growth, both companies successfully offset inflationary costs through favorable pricing, operational productivity initiatives and our synergy programs. As we move toward the end of our fiscal year, we are optimistic about our business outlook as our order book, project tracking, book-to-bill ratio and backlog continue to be favorable on a year-over-year basis. We are well positioned to capitalize on growing residential development and horizontal construction, while continuing to generate above-market growth through the execution of our material conversion and water management solutions strategies".
ooops-
Penn National reports Q4 EPS 7c, consensus 24c
1Life Healthcare price target raised to $62 from $42 at Citi 07:08 ONEM Citi analyst Daniel Grosslight raised the firm's price target on 1Life Healthcare to $62 from $42 and keeps a Buy rating on the shares. The anlasayt thinks 1Life's "vital role" in helping with COVID-19 vaccine distribution and administration provides incremental upside to 2021 net patient revenue estimates and will serve as a catalyst for membership growth acceleration.
Stony's PIPE stock--
Advanced Drainage reports Q3 EPS 62c, consensus 47c 06:51 WMS Reports Q3 revenue $486.1M, consensus $407.9M. CEO Scott Barbour commented, "We delivered a record Q3 in FY21. Sales grew 24% year-over-year, driven by 17% non-residential sales growth and 36% residential sales growth as we continued to execute on our material conversion strategy in the favorable demand environment. We experienced strong demand in key growth states in the South and Southeast regions of the U.S., as well as the return of demand in the Western and Northeast regions of the U.S. In addition, sales in the agriculture market increased 33%, driven by the programs we put in place around organizational changes, new product introductions and improving execution in the strong fall selling season. Overall, we executed well this quarter to meet the growing demand for our products and solutions and continue to benefit from our national presence as well as our favorable geographic and end market exposure. We also achieved record profitability in Q3. Our Adjusted EBITDA margin expanded 540-basis points this quarter, our first full quarter of comparable results from the Infiltrator business. In addition to capturing the benefits of leverage from our strong sales growth, both companies successfully offset inflationary costs through favorable pricing, operational productivity initiatives and our synergy programs. As we move toward the end of our fiscal year, we are optimistic about our business outlook as our order book, project tracking, book-to-bill ratio and backlog continue to be favorable on a year-over-year basis. We are well positioned to capitalize on growing residential development and horizontal construction, while continuing to generate above-market growth through the execution of our material conversion and water management solutions strategies".